Peroxiredoxin overexpression in MCF-7 breast cancer cells and regulation by cell proliferation and oxidative stress

Cancer Investigation

Volumn 31, Issue 6, 2013, Pages 374-384

  Tehan, Lauren ^a   Taparra, Kekoa ^a   Phelan, Shelley ^a  

^a FAIRFIELD UNIVERSITY   (United States)

Author keywords

Breast cancers; Gene expression; Signal transduction

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; PEROXIREDOXIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL DEATH; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MAMMAL; OXIDATIVE STRESS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; WESTERN BLOTTING;

ACETYLCYSTEINE; ANTHRACENES; ANTIOXIDANTS; BREAST NEOPLASMS; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FLAVONOIDS; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MCF-7 CELLS; OXIDATIVE STRESS; PEROXIREDOXINS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; UP-REGULATION;

EID: 84879473191     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357907.2013.802798     Document Type: Article

References (37)

1. Halliwell B, Gutteridge J. Free Radicals in Biology and Medicine, 3rd edition. New York: Oxford University Press, 1999
2. Halliwell B. Oxidative stress and cancer: Have we moved forward? Biochem J 2007;401:1-11 (Pubitemid 46115897)
3. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006;160:1-40 (Pubitemid 43227479)
4. Fujii J, Ikeda Y. Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein. Redox Rep 2002;7(3):123-130 (Pubitemid 34700435)
5. Hofmann B, Hecht HJ, Flohe L. Peroxiredoxins. Biol Chem 2002;383(3-4):347-364 (Pubitemid 34506276)
6. Wood ZA, Schröder E, Harris JR, Poole LB. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 2003;28(1):32-40 (Pubitemid 36051004)
7. Immenschuh S, Baumgart-Vogt E. Peroxiredoxins, oxidative stress, and cell proliferation. Antioxid Redox Signal 2005;7(5):768-777 (Pubitemid 40563217)
8. Rhee SG, Chae HZ, Kim K. Peroxiredoxins: A historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 2005;38: 1543-1552 (Pubitemid 40726061)
9. Butterfield LH, Merino A, Golub SH, Shau H. From cytoprotection to tumor suppression: The multifactorial role of peroxiredoxins. Antioxid Redox Signal 1999;1(4):385-402 (Pubitemid 129628306)
10. Noh DY, Ahn SJ, Lee RA, Kim SW, Park IA, Chae HZ. Overexpression of peroxiredoxin in human breast cancer. Anticancer Res 2001;21(3B):2085-2090
11. Kinnula VL, Lehtonen S, Sormunen R, Kaarteenaho-Wiik R, Kang SW, Rhee SG, Soini Y. Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma. J Pathol 2002;196(3):316-323 (Pubitemid 34189421)
12. Karihtala P, Mantyniemi A, Kang SW, Kinnula VL, Soini Y. Peroxiredoxins in breast carcinoma. Clin Cancer Res 2003;15(9):3418-3424 (Pubitemid 37082738)
13. Kinnula VL, Paakko P, Soini Y. Antioxidant enzymes and redox regulating thiol proteins in malignancies of human lung. FEBS Lett 2004;569(1-3):1-6 (Pubitemid 38844583)
14. Lehtonen ST, Svensk AM, Soini Y, Paakko P, Hirvikoski P, Kang SW, Saily M. Peroxiredoxins, a novel protein family in lung cancer. Int J Cancer 2004;111(4):514-521 (Pubitemid 39045317)
15. Quan C, Cha EJ, Lee HL, Han KH, Lee KM, Kim WJ. Enhanced expression of peroxiredoxin I. and V. I. correlates with development recurrence and progression of human bladder cancer. J Urol 2006;175(4):1512-1516
16. Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer. Breast Cancer Res 2007;9(6): R76
17. Basu A, Banerjee H, Rojas H,Martinez SR, Roy S SZ, Lilly MB, De Léon,M, Casiano CA.Differential expression of peroxiredoxins in prostate cancer: Consistent upregulation of PRDX3 and PRDX4. Prostate 2011;71:755-765
18. Maxwell GL, Hood BL, Day R, Chandran U, Kirchner D, Kolli VS, Bateman NW, Allard J,Miller C, SunM, Flint MS, Zahn C, Oliver J, Banerjee S, Litzi T, Parwani A, Sandburg G, Rose S, Becich MJ, BerchuckA,Kohn E, Risinger JI, Conrads TP. Proteomic analysis of stage I endometrial cancer tissue: Identification of proteins associated with oxidative processes and inflammation. Gynecol Oncol 2011;121(3):586-594
19. Berggren MI, Husbeck B, Samulitis B, Baker AF, Gallegos A, PowisG.Thioredoxin peroxidase-1 (peroxiredoxin-1) is increased in thioredoxin-1 transfected cells and results in enhanced protection against apoptosis caused by hydrogen peroxide but not by other agents including dexamethasone, etoposide, and doxorubicin. Arch Biochem Biophys 2001;392(1):103-109 (Pubitemid 32725020)
20. Chung YM, Yoo YD, Park JK, Kim YT, Kim HJ. Increased expression of peroxiredoxin II confers resistance to cisplatin. Anticancer Res 2001;21(2A):1129-1133
21. Husbeck B, Berggren MI, Powis G. DNA microarray reveals increased expression of thioredoxin peroxidase in thioredoxin-1 transfected cells and its functional consequences. Adv Exp Med Biol 2001;500:157-168 (Pubitemid 34106993)
22. Shen C, Nathan C. Nonredundant antioxidant defense bymultiple two-cysteine peroxiredoxins in human prostate cancer cells. Mol Med 2002;8(2):95-102 (Pubitemid 35013577)
23. Butzke D, Machuy N, Thiede B, Hurwitz R, Goedert S, Rudel T. Hydrogen peroxide produced byAplysia ink toxin kills tumor cells independent of apoptosis via peroxiredoxin I sensitive pathways. Cell Death Differ 2004;11(6):608-617 (Pubitemid 38786709)
24. Bae JY, Ahn SJ, Han W, Noh DYJ. Peroxiredoxin I and II inhibit H2O2-induced cell death in MCF-7 cell lines. Cell Biochem 2007;101(4):1038-1045 (Pubitemid 47040883)
25. Neumann CA, Fang Q. Are peroxiredoxins tumor suppressors? Curr Opin Pharm 2007;7(4):375-380 (Pubitemid 47289263)
26. Smith-Pearson PS, Kooshki M, Spitz DR, Poole LB, Zhao W, Robbins ME. Decreasing peroxiredoxin II expression decreases glutathione, alters cell cycle distribution, and sensitizes glioma cells to ionizing radiation and H(2)O(2). Free Radic Biol Med 2008;45(8):1178-1189
27. Demasi AP, Furuse C, Soares AB, Altemani A, Aráujo VC. Peroxiredoxin I, platelet-derived growth factor A, and platelet-derived growth factor receptor alpha are overexpressed in carcinoma ex pleomorphic adenoma: Association with malignant transformation. Hum Pathol 2009;40(3):390-397
28. Ishii T, Itoh K, Takahashi S, Sato H, Yanagawa T, Katoh Y, Bannai S, Yamamoto M. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 2000;275(21):16023-16029 (Pubitemid 30366908)
29. Shiota M, Izumi H, Miyamoto N, Onitsuka T, Kashiwagi E, Kidani A, Hirano G, Takahashi M, Ono M, Kuwano M, Naito S, Sasaguri Y, Kohno K. Ets regulates peroxiredoxin1 and 5 expressions through their interaction with the high-mobility group protein B1. Cancer Sci 2008;99(10):1950-1959
30. Baraibar MA, Hyzewicz J, Rogowska-Wrzesinska A, Ladouce R, Roepstorff P, Mouly V, Friguet B. Oxidative stressinduced proteome alterations target different cellular pathways in human myoblasts. Free Radic Biol Med 2011;51(8): 1522-1532
31. Goncalves K, Sullivan K, Phelan S. Differential expression and function of peroxiredoxin 1 and peroxiredoxin 6 in cancerous MCF-7 and noncancerous MCF-10A breast epithelial cells. Cancer Invest 2012;30(1):38-47
32. Park KJ, Kim YJ, Kim J, Kim SM, Lee SY, Bae JW, Hwang KK, Kim DW, Cho MC. Protective effects of peroxiredoxin on hydrogen peroxide induced oxidative stress and apoptosis in cardiomyocytes. Korean Circ J 2012;42(1):23-32
33. Livak K, Schmittgen T. Analysis of relative gene expression data using real-Time quantitative PCR and the 2-CT method.Methods Enzymol 2001;25:402-408 (Pubitemid 34164012)
34. Ho JN, Lee SB, Lee SS, Yoon SH, Kang GY, Hwang SG, Um HD. Phospholipase A2 activity of peroxiredoxin 6 promotes invasion and metastasis of lung cancer cells. Mol Cancer Ther 2010;9(4):825-832
35. ChaMK, Suh KH, KimIH.Overexpression of peroxiredoxin I and thioredoxin 1 in human breast carcinoma. J Exp Clin Cancer Res 2009;28:93-105
36. Chua PJ, Lee EH, Yu Y, Yip GW, Tan PH, Bay BH. Silencing the peroxiredoxin III gene inhibits cell proliferation in breast cancer. Int J Oncol 2010;36(2):359-364
37. Lee SU, Rhee M, Min YK, Kim SH. Involvement of peroxiredoxin IV in the 16α-hydroxyestrone-induced proliferation of human MCF-7 breast cancer cells. Cell Biol Int 2008;32(4):401-405